OXB.L Current Ratio

As of 2025-07-13, the Current Ratio of Oxford Biomedica PLC (OXB.L) is 2.28.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

OXB.L Current Ratio - Historical Value

Date	Value
2024-12-31	2.28
2023-12-31	3.19
2022-12-31	3.61
2021-12-31	4.92
2020-12-31	2.06
2019-12-31	1.97
2018-12-31	2.31
2017-12-31	1.7
2016-12-31	2.95
2015-12-31	-

OXB.L Current Ratio - Peers Comparison

Ticker	Name	Value
ABC.L	Abcam PLC	1.13
ABVX.PA	Abivax SA	1.82
ADAP	Adaptimmune Therapeutics PLC	2.92
ALBPS.PA	Biophytis SA	0.72
ALCLS.PA	Cellectis SA	1.73
AVCT.L	Avacta Group PLC	1.08
BCYC	Bicycle Therapeutics PLC	13.81
BGBIO.OL	Bergenbio ASA	4.79
BSLN.SW	Basilea Pharmaceutica AG Allschwil	4.85
BVXP.L	Bioventix PLC	7.42
CANTA.ST	Cantargia AB	3.04
CMPS	Compass Pathways PLC	5.92
CNTA	Centessa Pharmaceuticals PLC	9.25
FYB.DE	Formycon AG	2.8
GNS.L	Genus PLC	1.8
HNSA.ST	Hansa Biopharma AB	2.29
HPHA.DE	Heidelberg Pharma AG	5.95
IMCR	Immunocore Holdings PLC	4.39
IPH.PA	Innate Pharma SA	2.6
IVA.PA	Inventiva SA	0.92
IVACC.ST	Intervacc AB	2.03
KDS.AS	Kiadis Pharma NV	0.22
MAB.WA	Mabion SA	1.17
MOLN.SW	Molecular Partners AG	14.31
MXCT.L	MaxCyte Inc	3.9
MYOV	Myovant Sciences Ltd	1.95
NANO.PA	Nanobiotix SA	1.04
NANOV.OL	Nordic Nanovector ASA	2.46
ORPHA.CO	Orphazyme A/S	3.81
OSE.PA	OSE Immunotherapeutics SA	3.46
RLF.SW	Relief Therapeutics Holding SA	3.95
SIGHT.PA	Gensight Biologics SA	0.24
SLN.L	Silence Therapeutics PLC	2.99
SNG.L	Synairgen PLC	9.01
VVY.AS	Vivoryon Therapeutics NV	7.2
ZEAL.CO	Zealand Pharma A/S	21.14